Stocks of Physicians Realty Trust (DOC) are poised to climb above their peers

Physicians Realty Trust (NYSE: DOC) stock fell -1.52% on Friday to $15.59 against a previous-day closing price of $15.83. With 1.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.75 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $15.80 whereas the lowest price it dropped to was $15.57. The 52-week range on DOC shows that it touched its highest point at $19.30 and its lowest point at $15.66 during that stretch. It currently has a 1-year price target of $19.07. With its current market cap of 3.45 billion, DOC has annualized dividend of $0.92 while the current yield stands at 5.90%. Beta for the stock currently stands at 0.77.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DOC was down-trending over the past week, with a drop of -2.20%, but this was down by -9.78% over a month. Three-month performance dropped to -9.88% while six-month performance fell -9.15%. The stock lost -15.46% in the past year, while it has lost -17.21% so far this year. A look at the trailing 12-month EPS for DOC yields 0.35 with Next year EPS estimates of 0.27. For the next quarter, that number is 0.11. This implies an EPS growth rate of 22.30% for this year and -10.40% for next year. EPS is expected to grow by 9.70% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.70%.

Float and Shares Shorts:

At present, 225.62 million DOC shares are outstanding with a float of 224.25 million shares on hand for trading. On Jul 14, 2022, short shares totaled 10.72 million, which was 4.76% higher than short shares on Jun 14, 2022. In addition to Mr. John T. Thomas as the firm’s Pres, CEO & Trustee, Mr. Jeffrey Nelson Theiler serves as its Exec. VP, CFO & Head of Investor Relations.


Institutional Ownership:

Through their ownership of 92.51% of DOC’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 55.54% of DOC, in contrast to 39.53% held by mutual funds. Shares owned by individuals account for 1.03%. As the largest shareholder in DOC with 14.49% of the stake, The Vanguard Group, Inc. holds 32,788,814 shares worth 32,788,814. A second-largest stockholder of DOC, BlackRock Fund Advisors, holds 27,374,024 shares, controlling over 12.10% of the firm’s shares. AllianceBernstein LP is the third largest shareholder in DOC, holding 11,659,554 shares or 5.15% stake. With a 4.56% stake in DOC, the Vanguard Real Estate Index Fund is the largest stakeholder. A total of 10,318,085 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 2.94% of DOC stock, is the second-largest Mutual Fund holder. It holds 6,663,610 shares valued at 111.02 million. iShares Core S&P Mid Cap ETF holds 2.93% of the stake in DOC, owning 6,626,629 shares worth 110.4 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DOC since 17 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 11 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With DOC analysts setting a high price target of $21.00 and a low target of $16.50, the average target price over the next 12 months is $19.00. Based on these targets, DOC could surge 34.7% to reach the target high and rise by 5.84% to reach the target low. Reaching the average price target will result in a growth of 21.87% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. DOC will report FY 2022 earnings on 03/01/2023. Analysts have provided yearly estimates in a range of $0.30 being high and $0.22 being low. For DOC, this leads to a yearly average estimate of $0.26. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Physicians Realty Trust surprised analysts by $0.01 when it reported $0.07 EPS against a consensus estimate of $0.06. The surprise factor in the prior quarter was -$0.01. Based on analyst estimates, the high estimate for the next quarter is $0.07 and the low estimate is $0.05. The average estimate for the next quarter is thus $0.06.

Summary of Insider Activity:

Insiders traded DOC stock several times over the past three months with 0 Buys and 8 Sells. In these transactions, 0 shares were bought while 61,330 shares were sold. The number of buy transactions has increased to 39 while that of sell transactions has risen to 29 over the past year. The total number of shares bought during that period was 630,213 while 312,236 shares were sold.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]